APNEA TEK MEDICAL DEVICES

A Medical Device Research Company

A Division of Real 3D Polymers LLC

 
iStock-178054142 (1).jpg

SLEEP APNEA TREATMENT DEVICES

No-Mask, No Hose, Atmospheric Low Pressure CPAF® (Controlled Positive Air Flow) Device

 

FACTS & FIGURES

100M

Sleep Apnea Sufferers Worldwide

80M

Undiagnosed People

$150B

Economic Impact of Sleep Apnea in the US

 

ABOUT US

Apnea Tek Medical Devices (A Division of Real 3D Polymers LLC) is a Michigan-based medical device research company, developing several innovative sleep apnea treatment devices and directly 3D-printed teeth-straightening aligners. The company is co-founded by two industry veterans with experience in the field of medicine and across product, material, process development, commercialization.

 

PATENTS

Apnea Tek Medical Devices (Real 3D LLC) has FOUR GRANTED US patents, a continuation-in-part (CIP) patent, and one additional patent that has been filed with expedited review.

The international Patent Cooperation Treaty (PCT) application has been also filed.

Also, Granted Patent on "Directly 3D printing of Aligners"


 
Office Hallway
shutterstock_1476869840_edited.jpg
iStock-629586444 (1)_edited.jpg
Picture1.png

PROBLEM

Risks: High Blood Pressure, Diabetes, Concentration & Memory Problems, Depression, Heart Failure

CURRENT SOLUTIONS

CPAP Machines, Oral Appliances & Surgery

OUR SOLUTION

No-Mask CPAF®

 

PROBLEM

The American Academy of Sleep Medicine (AADSM) defines Obstructive sleep apnea (OSA) as: “A sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway.

There are 100 million Sleep Apnea Sufferers Worldwide and 80% are Undiagnosed. Frost & Sullivan calculated that the annual economic burden of undiagnosed sleep apnea among U.S. adults is approximately $149.6 billion. The estimated costs include $86.9 billion in lost productivity, $26.2 billion in motor vehicle accidents and $6.5 billion in workplace accidents.

Untreated sleep apnea also increases the risk of costly health complications such as hypertension, heart disease, diabetes, and depression. The report estimates that undiagnosed sleep apnea also costs $30 billion annually in increased health care utilization and medication costs related to these comorbid health risks. Reference

CURRENT SOLUTIONS

  • Large CPAP Machines: Continuous Positive Airway Pressure (CPAP) therapy accounts for 85% of diagnosed sleep apnea patients, yet nearly half don't comply with the therapy. CPAP devices are cumbersome, loud, uncomfortable and overall intrusive. Some patients have difficulty tolerating the forced air, can feel claustrophobic, and have a leaky mask or skin irritation.

  • Oral Appliances: Oral Appliances moves the lower jaw forward. The excessive movement can cause bite changes, TMJ pain, or pain in the jaws and teeth.

  • Surgery: Surgery can have complications and is cost-prohibitive.

Patients need a better option.

OUR SOLUTION

Over 6 years of research, we have developed first-of-its-kind miniature sleep apnea treatment device called the No-Mask CPAF® (Controlled Positive Air Flow). This device operates without a hose, mask, or nasal pillow, which results in comfortable sleep. CPAF®’s detachable miniature unit houses sensors, a micro-fan, and electronics, and is attached to the mouthpiece and capable of Bluetooth, wifi, or cellular connectivity. We are in preparation of filing with the FDA for approval in USA.

​The device brings air in at atmospheric pressure with the desired controlled flow rate – the air moves from the front of the mouth to rear of the throat, completely bypassing the tongue. It stabilizes the lower jaw and tongue, keeping airways open and free from obstruction during sleep. The device has capability of air stimulation of tongue and soft tissues which may not allow soft tissues to relax, keeping air passageway in throat area open during the sleep.

The customized 3D-printed device is made from FDA-approved medical grade material. It has high tensile strength and resistance to cracking and abrasion. It is also resistant to bruxism. The material is biocompatible and ensures the rarest levels of allergy and intolerances.​​

Current and future developments in our intellectual property portfolio include following concepts: 


  • Air-stimulation CPAF® (No implant) and Hybrid Air/Electric simulation Device 

  • Neurostimulation/Electric Stimulation) CPAF® (No implant)

  • Nasal CPAF®  Device

  • Sleep Position Control CPAF® Device

  • “Dual Purpose” (Sleep Apnea Treatment with directly 3D printed Aligner to straighten the teeth)  

 
 
Suresh Shah photo 2020.jpg

DR. SURESH SHAH

CEO & Co-founder

Plastics Hall of Fame inductee

SPE Lifetime Achievement Award recipient

Michigan ESD Scientist of the Year 

International SPE Research and Technology Award recipient

Dr. Shah has a background in Plastics/Polymers Materials, Product, Process and 3D Printing technology expert.

Office Hallway

OUR TEAM

Dr. Suresh Shah – CEO and Co-founder
Dr. D. M. Shah – Co-founder, passive investor and Medical Advisor 
Dr. Prasanna-Kumar Shivapuja, Orthodontist and Key Advisor (BDS, MDS, DDS, MS)
Dr. Avi Desai – Sleep Doctor and Pulmonary and critical care, Advisor
Dr. Earl Bogrow – Sleep Dentist. Diplomat of AADSM (American Academy of Dental Sleep Medicine)
Dr. Anjoo Ely - Sleep Dentist, Diplomat of AADSM
Dr. Regina Dailey – Sleep Dentist, Diplomat of AADSM
Laura Sheppard – Certified Dental Technician - SVP Clinical & Regulatory
Shail Chokhavatia – Vice President of Engineering, Sleep Apnea Expert
Udayan Patel – Vice President of Quality and Regulatory Affairs
Jitesh Desai – Vice President of Business Development and Marketing
Ankur Shah – Finance
Bruce Bennett II – Mechanical Design and Plastics Engineer
Nidhi Shah - Mechanical Engineer

 

GET IN TOUCH

Thanks for submitting!